Epidermal and dermal characteristics in skin equivalent after systemic and topical application of skin care ingredients

Annals of the New York Academy of Sciences

Volumn 1067, Issue 1, 2006, Pages 337-342

  Vicanova, Jana ^a,d   Bouez, Charbel ^b   Lacroix, Sophie ^b   Lindmark, Lars ^c   Damour, Odile ^b  

^a DermData sro   (Czech Republic)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Imedeen Research   (Denmark)

^d NONE   (Czech Republic)

Author keywords

Dermal matrix; Imedeen; Keratinocyte proliferation; Kinetin; Mimeskin; Skin equivalent

Indexed keywords

ASCORBIC ACID; BIOMARINE COMPLEX; COLLAGEN TYPE 1; ELASTIN; FIBRILLIN 1; FILAGGRIN; GRAPE SEED EXTRACT; IMEDEEN EXPRESSION LINE CONTROL SERUM; IMEDEEN TIME PERFECTION; KALININ; KI 67 ANTIGEN; KINETIN; NATURAL PRODUCT; PLANT EXTRACT; TOMATO EXTRACT; UNCLASSIFIED DRUG;

CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CUTANEOUS PARAMETERS; DERMIS; DERMOEPIDERMAL JUNCTION; DRUG FORMULATION; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; PHOTOAGING; SKIN CARE; SKIN EQUIVALENT; SKIN GRAFT; TOPICAL TREATMENT;

LYCOPERSICON ESCULENTUM; VITIS SP.;

EID: 33744459487     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1354.046     Document Type: Conference Paper

References (12)

1. Yaar, M., M. Eller & B. Gilchrest. 2002. Fifty years of skin aging. J. Invest. Dermatol. Symp. Proc. 7: 51 58.
2. Black, A.F., C. Bouez, E. Perrier, et al. 2005. Optimization and characterization of an engineered human skin equivalent. Tissue Eng. 11: 723 733.
3. Damour, O., C. Augustin & A.F. Black. 1998. Applications of reconstructed skin models in pharmaco-toxicological trials. Med. Biol. Eng. Comput. 6: 1 8.
4. Schlotmann, K., M. Kaeten, A.F. Black, et al. 2001. Cosmetic efficacy claims in vitro using a 3D human skin model. Int. J. Cosmet. Sci. 23: 309 318.
5. Duplan-Perrat, F., O. Damour, C. Montrocher, et al. 2000. Keratinocytes influence the maturation and organization of the elastin network in a skin equivalent. J. Invest. Dermatol. 114: 365 370.
6. Noblesse, E., V. Cenizo, C. Bouez, et al. 2004. Lysyl oxidase-like and lysyl oxidase are present in the dermis and epidermis of a skin equivalent and in human skin and are associated to elastic fibers. J. Invest. Dermatol. 122: 621 630.
7. Bouez, C., O. Damour & J. Vicanova. 2003. Improvement of dermal extracellular matrix structure and composition after treatment with Imedeen Time Perfection in an in vitro skin equivalent. Poster exhibited at meeting of International Society for Bioengineering and International Society for Skin Imaging. May, Hamburg, Germany.
8. Kieffer, M.E. & J. Efsen. 1998. Imedeen® in the treatment of photoaged skin: an efficacy and safety trial over 12 months. J. Eur. Acad. Dermatol. Venereol. 11: 129 136.
9. Sigler, M.L. & P. Rasmussen. 2003. A placebo controlled study of an oral supplement (Imedeen Time Perfection) in improving the appearance of photodamaged skin. Poster exhibited at Meeting of European Academy of Dermato Venereology. October, Barcelona, Spain.
10. Rattan, S. & B. Clark. 1994. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem. Biophys. Res. Commun. 201: 665 672.
11. Barciszewski, J., S. Rattan, G. Siboska, et al. 1999. Kinetin - 45 years on. Plant Sci. 148: 37 45.
12. McCullough, J.L. & G.D. Weinstein. 2002. Clinical study of safety and efficacy of using topical kinetin 0.1% (Kinerase) to treat photodamaged skin. Cosmet. Dermatol. 15: 29 32.